1. Pharmaceuticals and Drug Development

Stealth BioTherapeutics Announces Positive Vote from FDA Advisory Committee Meeting Supporting Potential Approval of Elamipretide for the Treatment of Barth Syndrome

Written by Posted on Less than 0 min read

NEEDHAM, Mass., Oct. 11, 2024 /PRNewswire/ — Stealth BioTherapeutics Inc. (the “Company” or “Stealth”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel…

Member since

More from Admin

Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Arcutis’ Zoryve (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age

WESTLAKE VILLAGE, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Zoryve (roflumilast) cream, 0.15%, for the treatment of mild to moderate atopic […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Sun Pharma Announces US FDA Filing Acceptance of New Drug Application for Deuruxolitinib

Treatment for: Alopecia Areata Sun Pharma Announces US FDA Filing Acceptance of New Drug Application for Deuruxolitinib Mumbai, INDIA and Princeton, N.J., October 06, 2023 – Sun Pharmaceutical Industries Ltd (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries or associate companies) today announced that the U.S. Food and […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

Treatment for: Low-Grade Glioma Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) BRISBANE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Scientists uncover new way viruses fight back against bacteria

A microscopic discovery will not only enable scientists to understand the microbial world around us but could also provide a new way to control CRISPR-Cas biotechnologies. An international team of researchers led by Professor Peter Fineran from the University of Otago and Dr Rafael Pinilla-Redondo from the University of Copenhagen has published a study in […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Caterpillars can detect their predators by the static electricity they emit

Caterpillars respond defensively to electric fields similar to those emitted by their natural predators, scientists at the University of Bristol have found. In the study, published today in the journal PNAS, experts showed that caterpillar hairs move in response to electric fields and are most sensitive to the frequencies that correspond to the wingbeats frequencies […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Flamingos don’t preen more than other waterbirds

Despite their famously fancy feathers, flamingos don’t spent more time preening than other waterbirds, new research shows. Scientists watched five of the world’s six flamingo species to see how they spend their time. While preening time varied, overall flamingos were roughly average compared to existing studies of other waterbirds. The researchers also examined time spent […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Genetic signatures of domestication identified in pigs, chickens

Wild boars and red junglefowl gave rise to common pigs and chickens. These animals’ genes evolved to express themselves differently, leading to signatures of domestication — such as weaker bones and better viral resistance — in pigs and chickens, according to a research team based in Japan. The findings, published on July 6 in Animals, […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

450-million-year-old organism finds new life in Softbotics

Researchers in the Department of Mechanical Engineering at Carnegie Mellon University, in collaboration with paleontologists from Spain and Poland, used fossil evidence to engineer a soft robotic replica of pleurocystitid, a marine organism that existed nearly 450 million years ago and is believed to be one of the first echinoderms capable of movement using a […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Climate change may lead to shifts in vital Pacific Arctic fisheries

Marine fisheries are an essential source of protein for a large part of the world’s population, as well as supporting around 390 million livelihoods and an industry worth approximately US$ 141 billion, according to the UN FAO. Yet, climate change presents a major threat to the world’s fisheries, particularly in the Pacific Arctic. The eastern […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Not so selfish after all: Viruses use freeloading genes as weapons

Curious bits of DNA tucked inside genomes across all kingdoms of life historically have been disregarded since they don’t seem to have a role to play in the competition for survival. Or so researchers thought. These DNA pieces came to be known as “selfish genetic elements” because they exist, as far as scientists could tell, […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

As we age, our cells are much less prone to specific longer genes

Ageing could also be much less about particular “ageing genes” and extra about how lengthy a gene is. Lots of the adjustments related to ageing may very well be occurring as a result of decreased expression of lengthy genes, say researchers in an opinion piece publishing March 21 within the journal Tendencies in Genetics. A […]
Written by
  1. Clinical

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

SOUTH SAN FRANSCISO, Calif., June 04, 2024. Surrozen, Inc. (“Surrozen” or the “Company”), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today announced that the first patient has been dosed in its Phase 1b clinical trial for SZN-043 in patients with severe alcohol-associated hepatitis. The Phase 1b […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Allergan Aesthetics Announces Positive Topline Results from Two Pivotal Phase 3 Studies of TrenibotulinumtoxinE (BoNT/E) for the Treatment of Glabellar Lines

IRVINE, Calif., Oct. 24, 2023 /PRNewswire/ — Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced positive topline results from two pivotal Phase 3 clinical studies evaluating trenibotulinumtoxinE (BoNT/E) for the treatment of moderate to severe glabellar lines (M21-500 and M21-508). The Phase 3 multicenter, randomized, double-blind, placebo-controlled studies evaluated the safety and efficacy of […]
Written by
  1. Clinical

NRx Prescribed drugs Pronounces Information-Lock of Part 2b/3 Trial of NRX-101 in Suicidal Therapy Resistant Bipolar Despair

RADNOR, Pa., April 8, 2024. NRx Prescribed drugs, Inc. (“NRx Prescribed drugs”, the “Firm”), a clinical-stage biopharmaceutical firm, at this time introduced that the Firm has achieved data-lock in its Part 2b/3 Suicidal Therapy Resistant Bipolar Despair Research with NRX-101. With data-lock, as forecast in final week’s earnings name, the whole information set handed on […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Phase 2 Spring Trial Of LHP588, Treatment For P. Gingivalis-positive Alzheimer’s Disease Proceeds

SAN FRANCISCO, Nov. 16, 2023. Lighthouse Pharmaceuticals, a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of Alzheimer’s and other diseases of aging, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for LHP588, the company’s next-generation gingipain inhibitor, for the treatment of P. gingivalis-positive […]
Written by
  1. Clinical

Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer’s Association International Conference® 2024 (AAIC®)

SOUTH SAN FRANCISCO, Calif., July 28, 2024 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the presentation of a poster on baseline characteristics for the global INVOKE-2 Phase 2 clinical trial evaluating the safety and efficacy of AL002 in slowing disease progression in individuals with early Alzheimer’s disease […]
Written by
  1. Nonclinical

Shifting Perspectives: Embracing Nonclinical Roles in the Medical Field

Title: Shifting Perspectives: Embracing Nonclinical Roles in the Medical Field Introduction: In the ever-evolving landscape of the medical field, there has been a notable shift in perspectives and an increasing recognition of the value of nonclinical roles. While traditionally, the medical field primarily revolved around doctors and nurses, there is now a growing appreciation for […]
Written by
  1. Biology

Physicists unlock the secret of elusive quantum negative entanglement

This study is led by Dr. Xiangdong Zhang (Key Laboratory of Advanced Optoelectronic Quantum Architecture and Measurements of Ministry of Education, Beijing Key Laboratory of Nanophotonics and Ultrafine Optoelectronic Systems and Beijing Institute of Technology), Dr. Ching Hua Lee (National University of Singapore and International Campus of Tianjin University), Dr. Yee Sin Ang (Singapore University […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: Stealth BioTherapeutics Announces Positive Vote from FDA Advisory Committee Meeting Supporting Potential Approval of Elamipretide for the Treatment of Barth Syndrome

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.